Brandon Price
Former EVP at Nascent Biotech and serial entrepreneur in biopharmaceuticals
Dr. Price is a scientist, businessman and entrepreneur, with more than 30 years in the biopharmaceutical industry. He is currently Executive Vice President of Business Development at Nascent Biotech (a clinical-stage public company developing cancer biologic drugs) and, with Dr. Fernando Larios, he has formed Biogenin, S.A.P.I. de C.V., located in Guadalajara, Mexico, which is developing and licensing new human and veterinary pharmaceuticals primarily for the Latin American market.
Dr. Price has been CEO of GalenBio, Inc, a synthetic vaccine company, Oncometa Pharmaceuticals, Inc., a small molecule company developing cancer and metabolic disorder drugs, Cognate Therapeutics, a stem cell company, President and CEO of Goodwin Biotechnology, a biologics contract manufacturing organization and he was the first CEO of CropTech Corporation, where he wrote the company's business plan and raised its first round of private financing.
He has served as Board Chairman of the Virginia Biotechnology Association and Maryland's counterpart, MdBIO. Dr. Price was named as the 2001 Biotechnology Leader of the Year in Virginia and was appointed by Governor Warner as co-chair of the Virginia Biotechnology Initiative. He currently sits on the Boards of OcuSciences, Inc. (Ann Arbor, MI), LumaCyte LLC (Charlottesville, VA) and Nascent Biotech, Inc. (Vero Beach, FL).
He holds the B.S. and Ph.D. degrees in Biophysics from the University of Michigan in Ann Arbor and is the author of more than 50 articles in the scientific and business literature.